Abstract
The assessment of the safety and efficacy of a new thrombolytic regimen (assent)-3 investigators. efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the assent-3 randomized trial in acute myocardial infarction
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have